| scholarly article | Q13442814 |
| P50 | author | Gaetano Serviddio | Q57339752 |
| P2093 | author name string | G Poli | |
| N Zarkovic | |||
| F Biasi | |||
| E Chiarpotto | |||
| D Zanetti | |||
| L Tessitore | |||
| J C Cutrin | |||
| B Zingaro | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability | Q24319995 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Mechanism of activation of the TGF-beta receptor | Q28245861 | ||
| Estrogen induces apoptosis in a rat prostatic adenocarcinoma: association with an increased expression of TGF-beta 1 and its type-I and type-II receptors | Q28580585 | ||
| The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand | Q28631127 | ||
| Pathogenesis of liver fibrosis: role of oxidative stress | Q34025940 | ||
| Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents | Q34211128 | ||
| TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors | Q36235100 | ||
| Transforming growth factor-beta. | Q36356739 | ||
| Down-regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development | Q36620077 | ||
| A chimeric serine/threonine kinase receptor system reveals the potential of multiple type II receptors to cooperate with transforming growth factor-beta type I receptor | Q40243393 | ||
| Lipid peroxidation and cancer | Q40719315 | ||
| Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). | Q40883581 | ||
| Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells. | Q40971976 | ||
| TGFbeta signaling: receptors, transducers, and Mad proteins. | Q41010880 | ||
| Tumor suppressor activity of the TGF-beta pathway in human cancers | Q41157801 | ||
| Type II TGF(beta) receptor expression in intestinal cell lines and in the intestinal tract | Q41202741 | ||
| Oxidative damage and fibrogenesis | Q41260212 | ||
| Role of transforming growth factor-beta in tissue injury and repair | Q41333076 | ||
| Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta. | Q41449097 | ||
| A single heteromeric receptor complex is sufficient to mediate biological effects of transforming growth factor-beta ligands | Q41466909 | ||
| Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities. | Q41552765 | ||
| The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis | Q44762612 | ||
| Regulation of the transforming growth factor-beta 1 and -beta 3 promoters by transcription factor Sp1. | Q52544786 | ||
| Microsatellite instability(MSI) in non-small cell lung cancer(NSCLC) is highly associated with transforming growth factor-beta type II receptor(TGF-beta RII) frameshift mutation. | Q53407186 | ||
| Reduced transforming growth factor-beta type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung. | Q53424031 | ||
| Oxidative damage and transforming growth factor beta 1 expression in pretumoral and tumoral lesions of human intestine. | Q54333185 | ||
| Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver | Q68019152 | ||
| Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal | Q68592280 | ||
| Fluorescent substances in mouse and human sera as a parameter of in vivo lipid peroxidation | Q70105244 | ||
| Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells | Q72724641 | ||
| Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells | Q72883339 | ||
| Genetic alterations of sporadic colorectal cancer with microsatellite instability, especially characteristics of primary multiple colorectal cancers | Q74234550 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tumor progression | Q16909647 |
| colon cancer | Q18555025 | ||
| P304 | page(s) | 361-367 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression | |
| P478 | volume | 50 |
| Q34218956 | 4-hydroxynonenal as a bioactive marker of pathophysiological processes |
| Q51034383 | Activity of superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase in different stages of colorectal carcinoma. |
| Q27693875 | Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance |
| Q58702537 | Cell-Type-Specific Modulation of Hydrogen Peroxide Cytotoxicity and 4-Hydroxynonenal Binding to Human Cellular Proteins In Vitro by Antioxidant Extract |
| Q28211171 | Changes in T-plastin expression with human trophoblast differentation |
| Q51649444 | Cholest-4-en-3-one attenuates TGF-β responsiveness by inducing TGF-β receptors degradation in Mv1Lu cells and colorectal adenocarcinoma cells. |
| Q39860298 | Ciprofloxacin decreases survival in HT-29 cells via the induction of TGF-beta1 secretion and enhances the anti-proliferative effect of 5-fluorouracil |
| Q42704793 | Colorectal cancer and pollution |
| Q40177301 | Differential sensitivity to 4-hydroxynonenal for normal and malignant mesenchymal cells |
| Q48562415 | Effect of Propofol, Sevoflurane and Desflurane on systemic redox balance |
| Q40473801 | Effect of deleted pancreatic cancer locus 4 gene transfection on biological behaviors of human colorectal carcinoma cells. |
| Q39793056 | Effects of Lipid Peroxidation-Derived Products on the Growth of Human Colorectal Cancer Cell Line HT-29. |
| Q53526526 | Estimation of serum malondialdehyde and assessment of DNA damage using comet assay in patients with oral submucous fibrosis. |
| Q46330360 | Evaluation of oxidative stress in colorectal cancer patients |
| Q37258771 | Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. |
| Q46429711 | Inhaled nitric oxide improves the survival of the paraquat-injured rats. |
| Q34278484 | Large differences in global transcriptional regulatory programs of normal and tumor colon cells |
| Q43157773 | Lipid peroxidation product acrolein as a predictive biomarker of prostate carcinoma relapse after radical surgery |
| Q34704784 | Mechanisms of oxysterol-induced carcinogenesis. |
| Q53087003 | Modulating effect of d-carvone on 1,2-dimethylhydrazine-induced pre-neoplastic lesions, oxidative stress and biotransforming enzymes, in an experimental model of rat colon carcinogenesis. |
| Q43120227 | Molecular signaling operated by a diet-compatible mixture of oxysterols in up-regulating CD36 receptor in CD68 positive cells |
| Q26828757 | On the role of 4-hydroxynonenal in health and disease |
| Q38297356 | Overview on major lipid peroxidation bioactive factor 4-hydroxynonenal as pluripotent growth-regulating factor. |
| Q34137628 | Pathological aspects of lipid peroxidation. |
| Q34359140 | Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract |
| Q45147373 | Quinoxaline 1,4-dioxides induce G2/M cell cycle arrest and apoptosis in human colon cancer cells |
| Q37457030 | Relation between gastric cancer and protein oxidation, DNA damage, and lipid peroxidation. |
| Q40622411 | TGFbeta1 expression in colonic mucosa: modulation by dietary lipids |
| Q89804445 | The Appearance of 4-Hydroxy-2-Nonenal (HNE) in Squamous Cell Carcinoma of the Oropharynx |
| Q64888598 | The Role of Acrolein and NADPH Oxidase in the Granulocyte-Mediated Growth-Inhibition of Tumor Cells. |
| Q44510029 | The contribution of animal fat oxidation products to colon carcinogenesis, through modulation of TGF-beta1 signaling |
| Q43961037 | The distribution of 4-hydroxynonenal-modified proteins in gastric mucosa of duodenal peptic ulcer patients |
| Q53619613 | Tissue distribution of lipid peroxidation product acrolein in human colon carcinogenesis. |
| Q91760435 | Traumatic acid toxicity mechanisms in human breast cancer MCF-7 cells |
Search more.